Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1)

Journal of Clinical Investigation

Volumn 103, Issue 5, 1999, Pages 597-604

  Hiromura, Keiju ^a   Pippin, Jeffrey W ^a   Fero, Matthew L ^b   Roberts, James M ^b   Shankland, Stuart J ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; INFLAMMATORY DISEASE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0033104753     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5461     Document Type: Article

References (39)

1. Sherr, C.J., and Roberts, J.M. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149-1163.
2. Durand, B., Gao, F.-B., and Raff, M. 1997. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16:306-317.
3. Kip1 is expressed transiently in developing myotomes and enhances myogenesis. Cell Growth Differ. 9:1-11.
4. Nourse, J., et al. 1994. Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature. 372:570-573.
5. Polyak, K., et al. 1994. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell. 78:59-66.
6. Shankland, S.J., et al. 1997. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1. Kidney Int. 51:1088-1099.
7. Schoecklmann, H.O., Rupprecht, H.D., Zauner, I., and Sterzel, R.B. 1996. TGF-β1 induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-CDK2 activation and retinoblastoma protein phosphorylation. Kidney Int. 51:1228-1236.
8. Shankland, S.J., et al. 1996. Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int. 50:1230-1239.
9. Kip1 safeguards against inflammatory injury. Nat. Med. 4:575-580.
10. Shankland, S.J., et al. 1997. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int. 52:404-413.
11. Rosenblatt, J., Gu, Y., and Morgan, D.O. 1992. Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A. Proc. Natl. Acad. Sci. USA. 89:2824-2828.
12. Hoang, A.T., Cohen, K.J., Barrett, J.F., Bergstrom, D.A., and Dang, C.V. 1994. Participation of cyclin A in Myc-induced apoptosis. Proc. Natl. Acad. Sci. USA. 91:6875-6879.
13. Meikrantz, W., Gisselbrecht, S., Tam, S.W., and Schlegel, R. 1994. Activation of cyclin A-dependent protein kinase during apoptosis. Proc. Natl. Acad. Sci. USA. 91:3754-3758.
14. Shi, L., et al. 1996. Granzyme B induces apoptosis and cyclin A-associated cyclin-dependent kinase activity in all stages of the cell cycle. J. Immunol. 157:2381-2385.
15. Zhou, B.-B., Li, H., Yuan, J., and Kirschner, M.W. 1998. Caspace-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc. Natl. Acad. Sci. USA. 95:6785-6790.
16. Savill, J. 1997. Apoptosis in resolution of inflammation. J. Leukoc. Biol. 61:375-380.
17. Thompson, C.B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456-1462.
18. Baket, A.J., et al. 1994. Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94:2105-2116.
19. Fero, M.L. 1996. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice. Cell. 85:733-744.
20. Coats S., Flanagan, W.M., Nourse J., and Roberts, J.M. 1996. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science. 272:877-880.
21. Meijer, L. 1996. Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 6:393-397.
22. Meijer, L., et al. 1996. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur. J. Biochem. 243:527-536.
23. Polyak, K., et al. 1994. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 8:9-22.
24. Shimizu, A., et al. 1995. Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int. 47:114-121.
25. Tashiro, K., et al. 1998. Detection of apoptotic cells in glomeruli of patients with IgA nephropathy. Nephron. 79:21-27.
26. Eastman, A. 1995. Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. Semin. Cancer Biol. 6:45-52.
27. Wang, J., and Walsh, K. 1996, Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science. 273:359-361.
28. Polyak, K., Waldman, T., He, T.C., Kinzler, K.W., and Vogelstein, B. 1996. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1945-1952.
29. Poluha, W., et al. 1996. The cyclin-dependent kinase inhibitor p21 (waf1) is required for survival of differentiating neuroblastoma cells. Mol. Cell. Biol. 16:1335-1341.
30. Gorospe, M., et al. 1997 p21 (Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14:929-935.
31. Yan, Y., Frisen, J., Lee, M.H., Massague, J., and Barbacid, M. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:973-983.
32. Zhang, P., et al. 1997. Altered cell differentiation and proliferation in mice lacking p57Kip2 indicates a role in Beckwith-Wiedermann syndrome. Nature. 387:151-158.
33. Levkau, B., et al. 1998. Cleavage of p21 (Cip1/Waf1) and p27 (Kip1) mediates apoptosis in endothelial cells through activation of CDK2: role of a caspase cascade. Mol. Cell. 1:553-563.
34. Park, D.S., Farinelli, S.E., and Green, LA. 1996. Inhibitors of cyclin-dependent kinases promote survival of post mitotic neuronally differentiated PC12 cells and sympathetic neurons. J. Biol. Chem. 271:8161-8169.
35. Ohtsubo, M., and Roberts, J.M. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science. 259:1908-1912.
36. Ohtsubo, M., Theodoras, A.M., Schumacher, J., Roberts, J.M., and Pagano, M. 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
37. Girard, F., Strausfeld, U., Fernandez, A., and Lamb, N. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell. 67:1169-1179.
38. Meikrantz, W., and Schlegel, R. 1996. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J. Biol. Chem. 271:10205-10209.
39. Harvey, K.J., Blomquist, J.F., and Ucker, D.S. 1998. Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2, caspace, and cyclin-dependent kinase activities. Mol. Cell. Biol. 18:2912-2922.